CIPROFLAXACIN Side Effects

6907354-2 | Erythema, Joint Swelling, Treatment Failure
on Jul 17, 2010 Male patient from AUSTRALIA , 46 years of age, was diagnosed with mycobacterium ulcerans infection and was treated with Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, joint swelling, treatment failure. Ciproflaxacin dosage: 500mg, Bid. During the same period patient was treated with RIFAMPICIN (300 Mg) (View Rifampicin Review and Rifampicin Label ). Patient was hospitalized.

6907353-0 | Bacterial Infection, Cellulitis, Joint Swelling
Patient was taking Ciproflaxacin (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), cellulitis (What is cellulitis?), joint swelling on Jul 17, 2010 from RUSSIAN FEDERATION Additional patient health information: Male patient , 66 years of age, was diagnosed with mycobacterium ulcerans infection and. Ciproflaxacin dosage: 500mg, Bid. During the same period patient was treated with RIFAMPIN (RIFADIN) (300 Mg, Bid) (View Rifampin (rifadin) Review and Rifampin (rifadin) Label ). Patient was hospitalized.

6672513-3 | Blood Creatinine Increased, Blood Urea Increased, Pneumonitis
Adverse event was reported on Apr 07, 2010 by a Female patient taking Ciproflaxacin (View Usage) (Dosage: 500mg Po Bid) was diagnosed with bronchitis (What is bronchitis?), pneumonitis and. Location: UNITED STATES , 60 years of age, weighting 195.0 lb, After Ciproflaxacin was administered, patient had the following side effects: blood creatinine increased, blood urea increased, pneumonitis. During the same period patient was treated with LEVAQUIN (250 G Po Q48 Hr) (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

6565949-2 | Toxic Epidermal Necrolysis
on Jan 29, 2010 Male patient from UNITED STATES , 53 years of age, weighting 176.4 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis. Ciproflaxacin dosage: Once Daily Po. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ).


6554954-8 | Cardiac Disorder, Palpitations, Rotator Cuff Syndrome, Vision Blurred
on Jan 26, 2010 Male patient from UNITED STATES , 35 years of age, weighting 210.0 lb, was diagnosed with gastroenteritis viral and was treated with Ciproflaxacin (View Usage). Patient had the following side effects: cardiac disorder, palpitations, rotator cuff syndrome, vision blurred. Ciproflaxacin dosage: 500mg Twice A Day Po. Patient was hospitalized.

6544761-4 | Arthralgia, Asthenia, Ataxia, Cachexia, Diarrhoea, Headache, Hypertension, Malaise, Muscle Spasms
Patient was taking Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: arthralgia, asthenia, ataxia (What is ataxia?), cachexia, diarrhoea, headache (What is headache?), hypertension, malaise, muscle spasms on Jan 20, 2010 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 238.0 lb, was diagnosed with gastrointestinal infection and. Ciproflaxacin dosage: 250mg Bid Po.

6538596-6 | Pruritus, Tendon Rupture
Adverse event was reported on Jan 13, 2010 by a Female patient taking Ciproflaxacin (View Usage) (Dosage: 500mg Bid Po) was diagnosed with diverticulitis and. Location: UNITED STATES , weighting 158.0 lb, Patient experienced the following unwanted or unexpected effects: pruritus, tendon rupture. During the same period patient was treated with METRONIDAZOLE (250 Mg Tid Po) (View Metronidazole Review and Metronidazole Label ).

6499076-X | Blister
on Dec 01, 2009 Female patient from UNITED KINGDOM , 48 years of age, weighting 220.5 lb, was diagnosed with kidney infection and was treated with Ciproflaxacin (View Usage). Patient had the following side effects: blister. Ciproflaxacin dosage: . During the same period patient was treated with CO CODAMOL (View Co-codamol Review and Co-codamol Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ).

6477894-1 | Swelling, Tendon Pain
on Dec 03, 2009 Male patient from UNITED STATES , 60 years of age, weighting 230.0 lb, was diagnosed with prostatitis and was treated with Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: swelling, tendon pain. Ciproflaxacin dosage: 400mg Bid Po.

6443900-3 | Feeling Abnormal, Heart Rate Decreased, Loss Of Consciousness, Urinary Incontinence
Patient was taking Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: feeling abnormal, heart rate decreased, loss of consciousness, urinary incontinence (What is urinary incontinence?) on Oct 28, 2009 from CANADA Additional patient health information: Female patient , 45 years of age, weighting 216.1 lb, . Ciproflaxacin dosage: 400 Mg, 1 Day, Intravenous. During the same period patient was treated with DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), MORPHINE (View Morphine Review and Morphine Label ), PERCOCET (View Percocet Review and Percocet Label ).

6430272-3 | Aphasia, Confusional State, Dysphemia, Product Quality Issue, Speech Disorder
Adverse event was reported on Nov 04, 2009 by a Female patient taking Ciproflaxacin (View Usage) (Dosage: 500 Mg Tab Bid Po) was diagnosed with salmonellosis and. Location: UNITED STATES , 46 years of age, weighting 170.0 lb, Patient had the following side effects: aphasia (What is aphasia?), confusional state, dysphemia, product quality issue, speech disorder. During the same period patient was treated with YAZ (View Yaz Review and Yaz Label ), PROZAC (View Prozac Review and Prozac Label ), REQUIP (View Requip Review and Requip Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PROSOM (View Prosom Review and Prosom Label ), LOMOTIL (View Lomotil Review and Lomotil Label ). Patient was hospitalized.

6403728-7 | Musculoskeletal Pain, Tendon Rupture
on Oct 15, 2009 Male patient from UNITED STATES , 44 years of age, weighting 152.0 lb, was diagnosed with postoperative care, preoperative care and was treated with Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: musculoskeletal pain, tendon rupture. Ciproflaxacin dosage: 1 Tab Twice A Day Po. Patient was hospitalized and became disabled.

6403051-0 | Epicondylitis, Tendonitis
on Oct 15, 2009 Female patient from UNITED STATES , 52 years of age, weighting 150.0 lb, was diagnosed with tooth extraction and was treated with Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: epicondylitis, tendonitis. Ciproflaxacin dosage: 500mg Tablet Twice Daily Oral.

6371893-6 | Amnesia, Feeling Abnormal, Rash
Patient was taking Ciproflaxacin (View Usage). Patient had the following side effects: amnesia, feeling abnormal, rash (What is rash?) on Sep 18, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 153.0 lb, was diagnosed with bladder disorder, prostate infection and. Ciproflaxacin dosage: 500 Mg 2/day Po.

6369263-X | Body Temperature Increased, Clostridium Difficile Colitis, Culture Stool Positive, Dehydration, Hypotension, Nausea, Pseudomembranous Colitis, Pyrexia, Tachycardia
Adverse event was reported on Sep 08, 2009 by a Male patient taking Ciproflaxacin (View Usage) (Dosage: ) was diagnosed with mycobacterium abscessus infection, pseudomonas infection and. Location: UNITED KINGDOM , 34 years of age, After Ciproflaxacin was administered, patient had the following side effects: body temperature increased, clostridium difficile colitis, culture stool positive, dehydration, hypotension, nausea (What is nausea?), pseudomembranous colitis, pyrexia, tachycardia. During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ). Patient was hospitalized.

6366857-2 | Abdominal Pain, Plantar Fasciitis, Rash
on Sep 07, 2009 Female patient from SWEDEN , 40 years of age, was treated with Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), plantar fasciitis, rash (What is rash?). Ciproflaxacin dosage: . During the same period patient was treated with BRICANYL (View Bricanyl Review and Bricanyl Label ), PULMICORT 100 (View Pulmicort-100 Review and Pulmicort-100 Label ), MIRENA (View Mirena Review and Mirena Label ).

6366514-2 | Benign Prostatic Hyperplasia, Blood Creatine Phosphokinase Increased, Malaise, Myalgia, Pyrexia, Rhabdomyolysis, Sepsis, Urinary Tract Infection
on Sep 08, 2009 Male patient from UNITED STATES , 56 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), type 2 diabetes mellitus, benign prostatic hyperplasia and was treated with Ciproflaxacin (View Usage). Patient had the following side effects: benign prostatic hyperplasia, blood creatine phosphokinase increased, malaise, myalgia, pyrexia, rhabdomyolysis, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?). Ciproflaxacin dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ), HARNAL (View Harnal Review and Harnal Label ). Patient was hospitalized.

6361166-X | Blood Creatine Phosphokinase Increased, Malaise, Myalgia, Pyrexia, Rhabdomyolysis, Sepsis, Urinary Tract Infection
Patient was taking Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: blood creatine phosphokinase increased, malaise, myalgia, pyrexia, rhabdomyolysis, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?) on Sep 08, 2009 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), type 2 diabetes mellitus, benign prostatic hyperplasia and. Ciproflaxacin dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ), HARNAL (View Harnal Review and Harnal Label ). Patient was hospitalized.

6360729-5 | Abnormal Palmar/plantar Creases
Adverse event was reported on Sep 08, 2009 by a Female patient taking Ciproflaxacin (View Usage) (Dosage: 250 Mg, Bid) was diagnosed with lower respiratory tract infection and. Location: UNITED KINGDOM , weighting 7.34 lb, Patient experienced the following unwanted or unexpected effects: abnormal palmar/plantar creases.

6360310-8 | Blood Pressure Systolic Increased, International Normalised Ratio Increased, Microcytic Anaemia, Necrosis, Skin Discolouration, Ulcer
on Sep 11, 2009 Female patient from NETHERLANDS , 63 years of age, was diagnosed with infection (What is infection?), pain (What is pain?) and was treated with Ciproflaxacin (View Usage). Patient had the following side effects: blood pressure systolic increased, international normalised ratio increased, microcytic anaemia, necrosis, skin discolouration, ulcer (What is ulcer?). Ciproflaxacin dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), NADROPARIN (2850 E) (View Nadroparin Review and Nadroparin Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), PIRITRAMIDE (View Piritramide Review and Piritramide Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ). Patient was hospitalized.

6356659-5 | Chromaturia, Muscular Weakness, Myalgia
on Sep 14, 2009 Female patient from UNITED KINGDOM , 77 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), hyperlipidaemia and was treated with Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: chromaturia, muscular weakness, myalgia. Ciproflaxacin dosage: Two Doses/oral. During the same period patient was treated with SIMVASTATIN (40 Mg /day) (View Simvastatin Review and Simvastatin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), PINDOLOL (View Pindolol Review and Pindolol Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), NICORANDIOL (View Nicorandiol Review and Nicorandiol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6349603-8 | Abnormal Palmar/plantar Creases
Patient was taking Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal palmar/plantar creases on Sep 08, 2009 from UNITED KINGDOM Additional patient health information: Female patient , weighting 7.34 lb, . Ciproflaxacin dosage: .

6344035-0 | Injury, Ligament Injury, Tendon Rupture
Adverse event was reported on Sep 04, 2009 by a Male patient taking Ciproflaxacin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 55 years of age, Patient had the following side effects: injury, ligament injury, tendon rupture. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6341602-5 | Blister, Skin Discolouration
on Sep 02, 2009 Female patient from UNITED STATES , 57 years of age, was treated with Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: blister, skin discolouration. Ciproflaxacin dosage: Once, Oral - A Single Dose -. During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ). Patient was hospitalized.

6341598-6 | Cardiac Failure Acute, Dyskinesia, Muscle Spasms
on Sep 02, 2009 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure acute, dyskinesia, muscle spasms. Ciproflaxacin dosage: 250 Mg Bd Oral Use. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), METHYLOPA (View Methylopa Review and Methylopa Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ), MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LOSARTAN (View Losartan Review and Losartan Label ).

6341597-4 | Convulsion, Myopathy, Renal Failure Acute
Patient was taking Ciproflaxacin (View Usage). Patient had the following side effects: convulsion, myopathy, renal failure acute on Sep 02, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 24 years of age, was diagnosed with sinusitis (What is sinusitis?), urinary tract infection (What is urinary tract infection?) and. Ciproflaxacin dosage: .

6338581-3 | Treatment Failure
Adverse event was reported on Aug 24, 2009 by a Male patient taking Ciproflaxacin (View Usage) (Dosage: ) was diagnosed with osteomyelitis and. Location: UNITED KINGDOM , 42 years of age, After Ciproflaxacin was administered, patient had the following side effects: treatment failure. During the same period patient was treated with LINEZOLIDE (View Linezolide Review and Linezolide Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PYOSTACINE (Unk) (View Pyostacine Review and Pyostacine Label ).

6337373-9 | Photosensitivity Reaction, Pruritus, Rash
on Sep 01, 2009 Female patient from UNITED STATES , 54 years of age, weighting 134.0 lb, was treated with Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: photosensitivity reaction, pruritus, rash (What is rash?). Ciproflaxacin dosage: 250 Mg Bid Po.

6337121-2 | Anxiety, Asthenia, Derealisation, Insomnia, Nervous System Disorder, Tremor
on Aug 14, 2009 Male patient from , 53 years of age, weighting 147.3 lb, was diagnosed with prostatitis and was treated with Ciproflaxacin (View Usage). Patient had the following side effects: anxiety (What is anxiety?), asthenia, derealisation, insomnia, nervous system disorder, tremor. Ciproflaxacin dosage: 1g.

6336138-1 | Abdominal Pain, Haematochezia, Rectal Haemorrhage
Patient was taking Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), haematochezia, rectal haemorrhage on Aug 28, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 34 years of age, was diagnosed with sinusitis (What is sinusitis?) and. Ciproflaxacin dosage: 400 Mg Twicw Daily Oral. Patient was hospitalized.

6335460-2 | Jaundice, Liver Function Test Abnormal, Neutropenia, Thrombocytopenia, Urinary Tract Infection
Adverse event was reported on Aug 17, 2009 by a Male patient taking Ciproflaxacin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), hiv infection (What is hiv infection?), antifungal prophylaxis and. Location: UNITED KINGDOM , 54 years of age, Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?), liver function test abnormal, neutropenia, thrombocytopenia, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with VIRAMUNE (View Viramune Review and Viramune Label ), CEFRADINE (View Cefradine Review and Cefradine Label ), COTRIM (View Cotrim Review and Cotrim Label ), TETRACYCLINE (View Tetracycline Review and Tetracycline Label ), TRUVADA /01398801/ (View Truvada /01398801/ Review and Truvada /01398801/ Label ). Patient was hospitalized.

6334818-5 | Anxiety, Asthenia, Derealisation, Insomnia, Nervous System Disorder, Tremor
on Aug 13, 2009 Male patient from UNITED KINGDOM , 53 years of age, weighting 147.7 lb, was diagnosed with prostatitis and was treated with Ciproflaxacin (View Usage). Patient had the following side effects: anxiety (What is anxiety?), asthenia, derealisation, insomnia, nervous system disorder, tremor. Ciproflaxacin dosage: .

6334817-3 | Dyskinesia, Muscle Spasms, Renal Failure Acute
on Aug 14, 2009 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: dyskinesia, muscle spasms, renal failure acute. Ciproflaxacin dosage: As Used: 250 Mg. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ). Patient was hospitalized and became disabled.

6318271-3 | Rash
Patient was taking Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?) on Aug 20, 2009 from UNITED STATES Additional patient health information: Male patient , 57 years of age, was diagnosed with infection (What is infection?) and. Ciproflaxacin dosage: 500 Mg Bid Po. Patient was hospitalized.

6317411-X | Hypersensitivity
Adverse event was reported on Aug 20, 2009 by a Male patient taking Ciproflaxacin (View Usage) (Dosage: 750 Mg 2 Per Day 047) was diagnosed with enterobacter infection and. Location: UNITED STATES , weighting 207.0 lb, Patient had the following side effects: hypersensitivity.

6312685-3 | Tendonitis
on Aug 14, 2009 Male patient from UNITED STATES , 37 years of age, weighting 175.0 lb, was diagnosed with infection (What is infection?) and was treated with Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: tendonitis. Ciproflaxacin dosage: .

6250708-0 | Gastroenteritis Clostridial
on Jun 02, 2009 Male patient from GERMANY , 60 years of age, was diagnosed with tracheobronchitis and was treated with Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: gastroenteritis clostridial. Ciproflaxacin dosage: 500 Mg Bid Oral. During the same period patient was treated with COTRIMHEXAL FORTE TABLETS (SULFAMETHOXAZOLE TRIMETHOPRIM) (View Cotrimhexal Forte Tablets (sulfamethoxazole Trimethoprim) Review and Cotrimhexal Forte Tablets (sulfamethoxazole Trimethoprim) Label ), TAZOBAC IV (PIPERACILLIN AND TAZOBACTAM) (View Tazobac Iv (piperacillin And Tazobactam) Review and Tazobac Iv (piperacillin And Tazobactam) Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), FALHITHROM HEXAL (PHENPROCOUMON) (View Falhithrom Hexal (phenprocoumon) Review and Falhithrom Hexal (phenprocoumon) Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

6244748-5 | Hepatitis, Hepatotoxicity, International Normalised Ratio Increased, Renal Lipomatosis, Splenomegaly
Patient was taking Ciproflaxacin (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?), hepatotoxicity, international normalised ratio increased, renal lipomatosis, splenomegaly on Jun 15, 2009 from CANADA Additional patient health information: Female patient , 39 years of age, was diagnosed with abdominal pain lower, abscess (What is abscess?), diverticulum and. Ciproflaxacin dosage: 500 Mg Bid Oral. During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6242081-9 | Convulsion, Myopathy, Renal Failure Acute
Adverse event was reported on Jun 08, 2009 by a Female patient taking Ciproflaxacin (View Usage) (Dosage: ) was diagnosed with sinusitis (What is sinusitis?), urinary tract infection (What is urinary tract infection?) and. Location: TURKEY , 24 years of age, After Ciproflaxacin was administered, patient had the following side effects: convulsion, myopathy, renal failure acute. Patient was hospitalized.

6232644-9 | Anorexia, Anxiety, Dissociation, Fatigue, Feeling Abnormal, Hallucination, Auditory, Headache, Insomnia, Muscle Spasms
on Jun 12, 2009 Male patient from UNITED STATES , 34 years of age, weighting 145.0 lb, was diagnosed with epididymitis and was treated with Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, anxiety (What is anxiety?), dissociation, fatigue, feeling abnormal, hallucination, auditory, headache (What is headache?), insomnia, muscle spasms. Ciproflaxacin dosage: 1 Tablet Twice Daily Po.

6230826-3 | Gastroenteritis Clostridial
on Jun 02, 2009 Male patient from GERMANY , 60 years of age, was diagnosed with tracheobronchitis and was treated with Ciproflaxacin (View Usage). Patient had the following side effects: gastroenteritis clostridial. Ciproflaxacin dosage: 500 Mg Bid Oral. During the same period patient was treated with COTRIMHEXAL FORTE? TABLETS (SULFAMETHOXAZOLE TRIMETHOPRIM) (View Cotrimhexal Forte? Tablets (sulfamethoxazole Trimethoprim) Review and Cotrimhexal Forte? Tablets (sulfamethoxazole Trimethoprim) Label ), TAZOBAC? IV (PIPERACILLIN AND TAZOBACTAM) (View Tazobac? Iv (piperacillin And Tazobactam) Review and Tazobac? Iv (piperacillin And Tazobactam) Label ), ZITHROMAX? PFIZER (AZITHROMYCIN) (View Zithromax? Pfizer (azithromycin) Review and Zithromax? Pfizer (azithromycin) Label ), CELLCEPT? (MYCOPHENOLATE MOFETIL) (View Cellcept? (mycophenolate Mofetil) Review and Cellcept? (mycophenolate Mofetil) Label ), DECORTIN H? (PREDNISOLONE) (View Decortin-h? (prednisolone) Review and Decortin-h? (prednisolone) Label ), DUROGESIC ? (FENTANYL) (View Durogesic ? (fentanyl) Review and Durogesic ? (fentanyl) Label ), FALHITHROM HEXAL? (PHENPROCOUMON) (View Falhithrom Hexal? (phenprocoumon) Review and Falhithrom Hexal? (phenprocoumon) Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

6207805-5 | Condition Aggravated, Dyskinesia, Muscle Spasms, Renal Failure Acute
Patient was taking Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: condition aggravated, dyskinesia, muscle spasms, renal failure acute on May 07, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 68 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Ciproflaxacin dosage: 250 Mg; Twice A Day; Oral. During the same period patient was treated with ASPIRIN (CON.) (View Aspirin (con.) Review and Aspirin (con.) Label ), ATENOLOL (CON.) (View Atenolol (con.) Review and Atenolol (con.) Label ), ATORVASTATIN (CON.) (View Atorvastatin (con.) Review and Atorvastatin (con.) Label ), BENDROFLUAZIDE (CON.) (View Bendrofluazide (con.) Review and Bendrofluazide (con.) Label ), CO CODAMOL (CON.) (View Co-codamol (con.) Review and Co-codamol (con.) Label ), ENALAPRIL (CON.) (View Enalapril (con.) Review and Enalapril (con.) Label ), LATANOPROST (CON.) (View Latanoprost (con.) Review and Latanoprost (con.) Label ), LEVOTHYROXINE (CON.) (View Levothyroxine (con.) Review and Levothyroxine (con.) Label ). Patient was hospitalized and became disabled.

6160351-X | Ageusia, Arthralgia, Fatigue, Headache, Parosmia, Swelling Face
Adverse event was reported on Apr 15, 2009 by a Female patient taking Ciproflaxacin (View Usage) (Dosage: 500 Mg Every 12 Hours Po) was diagnosed with sinusitis (What is sinusitis?) and. Location: UNITED STATES , 49 years of age, weighting 345.0 lb, Patient experienced the following unwanted or unexpected effects: ageusia, arthralgia, fatigue, headache (What is headache?), parosmia, swelling face.

6130002-9 | Erythema
on Mar 23, 2009 Male patient from UNITED STATES , 72 years of age, weighting 233.0 lb, was diagnosed with decubitus ulcer and was treated with Ciproflaxacin (View Usage). Patient had the following side effects: erythema. Ciproflaxacin dosage: 500mg Bid Po 2 Doses. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (Double Strength Tab Bid Po 2 Doses) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), SILVADENE (View Silvadene Review and Silvadene Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), DIOVAN (View Diovan Review and Diovan Label ), LOTREL (View Lotrel Review and Lotrel Label ), CELEBREX (View Celebrex Review and Celebrex Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6129787-7 | Cerebrovascular Accident, Gait Disturbance, Impaired Work Ability, Muscle Spasms, Myalgia, Pain In Extremity, Tendonitis, Tremor
on Mar 23, 2009 Male patient from UNITED STATES , 45 years of age, weighting 230.0 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: cerebrovascular accident, gait disturbance, impaired work ability, muscle spasms, myalgia, pain in extremity, tendonitis, tremor. Ciproflaxacin dosage: 1 Twice Daily Po.

6088952-8 | Arthralgia, Joint Swelling, Pain In Extremity, Paraesthesia
Patient was taking Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, joint swelling, pain in extremity, paraesthesia on Feb 19, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 185.0 lb, was diagnosed with sinus disorder and. Ciproflaxacin dosage: 1 Pill 250mg 1 - 12 Hrs.

6064436-8 | Anxiety, Depression, Dizziness, Dyspnoea, Eye Movement Disorder, Faeces Discoloured, Feeling Abnormal, Haematochezia, Heart Rate Irregular
Adverse event was reported on Feb 03, 2009 by a Female patient taking Ciproflaxacin (View Usage) (Dosage: 500 Mg 1 Twice Daily) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 26 years of age, weighting 120.0 lb, Patient had the following side effects: anxiety (What is anxiety?), depression (What is depression?), dizziness (What is dizziness?), dyspnoea, eye movement disorder, faeces discoloured, feeling abnormal, haematochezia, heart rate irregular.

5892614-7 | Anxiety, Aphasia, Apnoea, Arthralgia, Chest Discomfort, Confusional State, Disturbance In Attention, Dizziness, Dysphagia
on Sep 19, 2008 Female patient from UNITED STATES , 35 years of age, weighting 130.0 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Ciproflaxacin (View Usage). After Ciproflaxacin was administered, patient had the following side effects: anxiety (What is anxiety?), aphasia (What is aphasia?), apnoea, arthralgia, chest discomfort, confusional state, disturbance in attention, dizziness (What is dizziness?), dysphagia. Ciproflaxacin dosage: .

5446122-8 | Activated Partial Thromboplastin Time Prolonged, Coagulopathy, International Normalised Ratio Increased
on Aug 14, 2007 Female patient from UNITED KINGDOM , 29 years of age, was treated with Ciproflaxacin (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, coagulopathy, international normalised ratio increased. Ciproflaxacin dosage: 800 Mg (400 Mg, 2 In 1 D);. During the same period patient was treated with TOBRAMYCIN (View Tobramycin Review and Tobramycin Label ).

5347127-8 | Blood Creatinine Increased, Crystal Urine Present, Incorrect Dose Administered, Nephropathy, Oliguria
Patient was taking Ciproflaxacin (View Usage). Patient had the following side effects: blood creatinine increased, crystal urine present, incorrect dose administered, nephropathy, oliguria on Apr 25, 2007 from UNITED STATES Additional patient health information: Female patient , 90 years of age, was diagnosed with proteus infection and. Ciproflaxacin dosage: 1500,00 Mg.